Detalles de la búsqueda
1.
Clinical and immunological control of experimental autoimmune encephalomyelitis by tolerogenic dendritic cells loaded with MOG-encoding mRNA.
J Neuroinflammation
; 16(1): 167, 2019 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31416452
2.
Th1Th17CM Lymphocyte Subpopulation as a Predictive Biomarker of Disease Activity in Multiple Sclerosis Patients under Dimethyl Fumarate or Fingolimod Treatment.
Mediators Inflamm
; 2019: 8147803, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31346315
3.
Cryopreserved vitamin D3-tolerogenic dendritic cells pulsed with autoantigens as a potential therapy for multiple sclerosis patients.
J Neuroinflammation
; 13(1): 113, 2016 05 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-27207486
4.
The mRNA-1273 Vaccine Induces Cross-Variant Antibody Responses to SARS-CoV-2 With Distinct Profiles in Individuals With or Without Pre-Existing Immunity.
Front Immunol
; 12: 737083, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34539673
5.
Combined Therapy of Vitamin D3-Tolerogenic Dendritic Cells and Interferon-ß in a Preclinical Model of Multiple Sclerosis.
Biomedicines
; 9(12)2021 Nov 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34944573
6.
Vitamin D3-Induced Tolerogenic Dendritic Cells Modulate the Transcriptomic Profile of T CD4+ Cells Towards a Functional Hyporesponsiveness.
Front Immunol
; 11: 599623, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33552054
7.
Ethyl Pyruvate Induces Tolerogenic Dendritic Cells.
Front Immunol
; 10: 157, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30792716
8.
Comparison of dendritic cells obtained from autoimmunty-prone and resistant rats.
Immunobiology
; 224(3): 470-476, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30765133
9.
MAP7 and MUCL1 Are Biomarkers of Vitamin D3-Induced Tolerogenic Dendritic Cells in Multiple Sclerosis Patients.
Front Immunol
; 10: 1251, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31293564
10.
Optimal response to dimethyl fumarate is mediated by a reduction of Th1-like Th17 cells after 3 months of treatment.
CNS Neurosci Ther
; 25(9): 995-1005, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31066225
11.
Tolerogenic dendritic cell-based treatment for multiple sclerosis (MS): a harmonised study protocol for two phase I clinical trials comparing intradermal and intranodal cell administration.
BMJ Open
; 9(9): e030309, 2019 09 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31501122
12.
Searching for the Transcriptomic Signature of Immune Tolerance Induction-Biomarkers of Safety and Functionality for Tolerogenic Dendritic Cells and Regulatory Macrophages.
Front Immunol
; 9: 2062, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30298066
13.
Comparative transcriptomic profile of tolerogenic dendritic cells differentiated with vitamin D3, dexamethasone and rapamycin.
Sci Rep
; 8(1): 14985, 2018 10 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30297862
14.
Monitoring CD49d Receptor Occupancy: A Method to Optimize and Personalize Natalizumab Therapy in Multiple Sclerosis Patients.
Cytometry B Clin Cytom
; 94(2): 327-333, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28378895
15.
Predicting therapeutic response to fingolimod treatment in multiple sclerosis patients.
CNS Neurosci Ther
; 24(12): 1175-1184, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29656444
16.
Liposome-based immunotherapy against autoimmune diseases: therapeutic effect on multiple sclerosis.
Nanomedicine (Lond)
; 12(11): 1231-1242, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28593827
17.
Beneficial effect of tolerogenic dendritic cells pulsed with MOG autoantigen in experimental autoimmune encephalomyelitis.
CNS Neurosci Ther
; 21(3): 222-30, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25403984
Resultados
1 -
17
de 17
1
Próxima >
>>